HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Finance In Brief

This article was originally published in The Rose Sheet

Executive Summary

Clarins first-half results: Operating profit increased 10.1% to $66.3 mil. (€1=$1.27) for the second half 2006 (ended June 30), Clarins reports Sept. 11. Firm attributes growth to a decline in manufacturing costs for the Beauty and Perfumes divisions, a positive currency effect and tight control of administrative costs. Operating profit for the Beauty division grew 9.9% to $56.5 mil. due to accelerated investments in a new communication campaign. Perfumes operating profit rose 11.4% to $9.77 mil., reflecting the continuing use of resources to support fragrances launched in 2005, firm says. Clarins first-half net revenues increased 8.5% like-for-like to $602.4 mil., firm reported July 27 (1"The Rose Sheet" July 31, 2006, In Brief)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel